The global drug screening market is projected to reach USD 11.6 billion by 2026, from USD 5.3 billion in 2021, at a CAGR of 16.8% during the forecast period. Market growth can be largely attributed to the growing drug & alcohol consumption and the enforcement of stringent laws mandating drug & alcohol testing, rising regulatory approvals for drug screening products & services. On the other hand, bans on alcohol consumption in Islamic countries and prohibitions on workplace drug testing in specific countries may hinder the growth of this market to a certain extent.
Drug screening services are expected to grow at the highest CAGR during the forecast period Drug screening market is segmented into products and services. In 2020,the services segment is expected to hold the largest share 57.4% of the drug screening market, growth in this segment is attributed to factors such growing drug & alcohol consumption worldwide, funding initiatives for drug testing laboratories, service launches and regulatory approvals, and geographic expansion of drug testing laboratories. • By sample type, urine samples are expected to dominate the market during the forecast period
The drug screening market is segmented into urine, breath, hair, oral, and other samples on the basis of sample type. The urine sample segment is expected to hold the largest share 61.5% of the drug screening market in 2020 due to the benefits it offers such as easy collection method, high accuracy in the detection of multiple drugs, cost-effectiveness, and instant results.
North America will dominate the market during the forecast period. Geographically, the drug screening market is segmented into North America, Europe, the Asia Pacific, and Rest of the World. In 2020, North America accounted for the largest share of 48.2% of the drug screening marke tfollowed by Europe. However, Asia Pacific is expected to register the highest CAGR 19.6% during the forecast period. The high growth of this regional segment is attributed due to the growing illicit consumption of drugs, the developing healthcare infrastructure and rising adoption of stringent regulatory guidelines for drug testing.
The primary interviews conducted for this report can be categorized as follows: • By Company Type -Tier 1: 57%, Tier 2: 30%,and Tier 3: 13% • By Designation - C-level:30%, D-level:45%, and Others:25% • By Region - North America:40%, Europe:19%, Asia Pacific:29%, and Rest of the World: 12%
Some of the prominent players operating in the drug screening market are LabCorp (US), Quest Diagnostics (US), Abbott Laboratories (US), OraSure Technologies (US), Alfa Scientific Designs (US), Thermo Fisher Scientific (US), Drägerwerk (Germany), LifeLoc (US), MPD Inc. (US), Omega Laboratories (US), Premier Biotech (US), Psychemedics (US), Roche (Switzerland), Shimadzu (Japan), and Siemens Healthineers (Germany).
Research Coverage: This report provides a detailed picture of the global drug screening market.It aims at estimating the size and future growth potential of the market across different segments, such as product and service, sample type, end user,and region.
The report also analyzes factors (such as drivers, restraints, and opportunities) affecting the market growth.It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders.
The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total drug screening market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report:
The report provides insights on the following pointers: • Market Penetration: Comprehensive information on drug screening offered by the top 25 players in the drug screening market. The report analyses the drug screening market by product and service, sample type, end user, and region. • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various drug screening across key geographic regions. • Market Diversification: Exhaustive information about new products and services, untapped geographies, recent developments, and investments in the drug screening market. • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the drug screening market.
Our reports have been used by over 10K customers, including:
The global drug of abuse testing market is predicted to reach US$ 6.6 Billion by 2027. The use of illicit drugs is increasing across the globe. According to the UN Office on Drugs and Crime (UNODC) World Drug Report 2021, about 5.5 percent of the population aged between 15 and 64 years have used drugs at least once in the past year, while...
The human microbiome market is projected to reach USD 1,370 million by 2029 from USD 269 million in 2023, at a CAGR of 31.1% from 2023 to 2029. The major factor driving the growth of the human microbiome market is the increasing focus on human microbiome therapy development. The human microbiome as a validated target for drug development &...
The infectious disease diagnostics market is expected to grow from US$ 23,890 million in 2021 to US$ 37,943.90 million by 2028; it is estimated to grow at a CAGR of 6.8% from 2021 to 2028. The report highlights trends prevailing in the market and factors driving the infectious disease diagnostics market growth. The market growth is attributed...
The Liver cancer diagnostics market size is projected to reach US$ US$ 15,951.77 million by 2028 from US$ 9,323.14 million in 2021; it is estimated to grow at a CAGR of 8.0% during 2021–2028. The report highlights the key factors driving the market and prominent players with their developments.The growth of the liver cancer diagnostics...
626 pages •
By Global Industry Analysts
• Feb 2022
Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares -Market presence across multiple geographies - Strong/Active/Niche/Trivial -Online interactive peer-to-peer collaborative bespoke updates -Access to our digital archives and MarketGlass...
The Infectious Disease Diagnostics Market was estimated to be USD 38,480.89 million in 2021 and is poised to grow at a CAGR of 3.79% by 2027 to reach USD 50,345.74 million. The COVID-19 pandemic has significantly impacted the infectious disease diagnostics market. Increasing incidences of infection in COVID-19 patients is anticipated...
The concussion market is expected to growth from US$ 7,211.89 million in 2021 to US$ 9,272.03 million by 2028. It is estimated to grow at a CAGR of 3.7% during 2021–2028. According to the Centers for Disease Control and Prevention (CDC) a concussion is a type of traumatic brain injury-or TBI caused by a bump, blow, or jolt to the head...
The molecular quality controls market size is expected to grow from USD 164 million in 2021 to USD 226 million by 2026, at a CAGR of 6.7% during the forecast period. The growth of this market is primarily driven by factors such as the rising adoption of third-party quality controls, increasing number of accredited clinical laboratories, the...
The global companion diagnostics market is projected to reach USD 9.9 billion by 2026 from USD 5.5 billion in 2021, at a CAGR of 12.6% during the forecast period. Market growth is driven by factors such as the growing significance of companion diagnostics in drug development and rising incidence of cancer and growing adoption of targeted therapies. "The...
The global sepsis diagnostics market size is expected to reach USD 771 million by 2026 from USD 503 million in 2021, at a CAGR of 8.9%. The demand is expected to grow due to the rising incidence of sepsis, a growing number of surgical procedures, high incidence of hospital-acquired infections, and increasing availability of a wide variety...
Surgical Procedures Performed
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.